TL
Tilray Brands, Inc.
TLRY · NASDAQ
$4.50 -0.22% (-$0.01)
1M +1.35%
Market Cap $506.6M
P/E Ratio -
Div. Yield -
ROE 7.95%
Piotroski F-Score Weak
3/9Valuation
44 /100
Fair P/B 0.31x
EV/EBITDA 41.88x
P/S 0.44x
Growth
26 /100
Declining Book val. growth 28.77%
Rev. growth 2.72%
FCF growth N/A
Profitability
10 /100
Weak Op. margin 5.18%
Gross margin 27.57%
FCF margin 9.87%
Quality
6 /100
Poor ROA 6.40%
ROIC 3.46%
Asset turnover 0.50x
Debt
45 /100
Moderate Int. coverage -2.31x
Debt/Equity 0.25x
Net debt/EBITDA 10.63x
Stability
15 /100
Unstable EPS volatility 428.66%
Beta 1.91x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TLRY
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Irwin David Simon
Employees
3,595
Headquarters
Leamington
Upcoming events
08 OCT
Earnings
Upcoming earnings report